NL-OMON29938已完成3 期
Anti-inflammatory effects of rosiglitazone in patients with stage 4 and 5 chronic kidney disease - Hercules
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •CKD, stage 4 (GFR <30/min), predialysis
排除标准
- •heart failure (NIHA 3 or 4), elevated liver enzymes
研究者
相似试验
进行中（未招募）
不适用
Anti-inflammatory effects of rosiglitazone in patients with stage 4 and 5 chronic kidney disease - HerculesChronic kidney diseaseEUCTR2006-003001-49-NLeiden University Medical Center200
尚未招募
4 期
Anti-inflammatory effects of pioglitazone in acute stroke - a double-blind placebo controlled trialAcute strokeStroke - IschaemicACTRN12605000174684Dr R W Simpson45
已完成
不适用
A comparison of the effects of rosiglitazone on endothelial function and arterial stiffness in insulin resistant individuals and normal controlsCardiovascular: Endothelial function and arterial stiffnessCirculatory SystemEndothelial function and arterial stiffnessISRCTN50847630Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)36
已完成
不适用
Does treatment with rosiglitazone result in improved pancreatic beta-cell function as compared to glimepiride in metformin treated diabetes type 2 patients?Diabetes mellitus type II (DM type II)Nutritional, Metabolic, EndocrineDiabetes mellitusISRCTN52245496Academic Medical Centre (AMC) (The Netherlands)22
撤回
2 期
Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney DiseaseInflammationChronic Kidney DiseaseNCT00169923Leiden University Medical Center200